New technologies for the detection of circulating tumour cells.
暂无分享,去创建一个
Nada Jabado | J. Rak | N. Gerges | N. Jabado | Janusz Rak | Noha Gerges
[1] Bjørn Naume,et al. Circulating and disseminated tumor cells. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] C. Cordon-Cardo,et al. Detection of prostatic specific membrane antigen messenger RNA using immunobead reverse transcriptase polymerase chain reaction. , 1999, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[3] S. Digumarthy,et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology , 2007, Nature.
[4] Anne Vincent-Salomon,et al. Circulating Tumor Cell Detection Predicts Early Metastatic Relapse After Neoadjuvant Chemotherapy in Large Operable and Locally Advanced Breast Cancer in a Phase II Randomized Trial , 2008, Clinical Cancer Research.
[5] Brigitte Rack,et al. Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System , 2007, Clinical Cancer Research.
[6] H. Juhl,et al. Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] R. Bast,et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] R. Coombes,et al. The clinical significance of disseminated tumor cells in breast cancer , 2007, Nature Clinical Practice Oncology.
[9] L. Sobin,et al. Classification of isolated tumor cells , 2003, Cancer.
[10] T. Dimpfl,et al. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. , 2000, The New England journal of medicine.
[11] C. Sotiriou,et al. Molecular detection and prognostic value of circulating cytokeratin-19 messenger RNA-positive and HER2 messenger RNA-positive cells in the peripheral blood of women with early-stage breast cancer. , 2007, Clinical breast cancer.
[12] Philip S Low,et al. In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry , 2007, Proceedings of the National Academy of Sciences.
[13] T. Fehm,et al. A pooled analysis of bone marrow micrometastasis in breast cancer. , 2005, The New England journal of medicine.
[14] A. Semjonow,et al. Asynchronous growth of prostate cancer is reflected by circulating tumor cells delivered from distinct, even small foci, harboring loss of heterozygosity of the PTEN gene. , 2006, Cancer research.
[15] L. Sobin,et al. How to improve the present TNM staging system , 1999, Cancer.
[16] I. Fidler,et al. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.
[17] Robert S. Kerbel,et al. The multifaceted circulating endothelial cell in cancer: towards marker and target identification , 2006, Nature Reviews Cancer.
[18] S. Burchill,et al. The molecular detection of circulating tumour cells. , 1995, British Journal of Cancer.
[19] Anne Vincent-Salomon,et al. Clinical Significance of Immunocytochemical Detection of Tumor Cells Using Digital Microscopy in Peripheral Blood and Bone Marrow of Breast Cancer Patients , 2004, Clinical Cancer Research.
[20] I. Fidler,et al. Critical determinants of cancer metastasis: rationale for therapy , 1999, Cancer Chemotherapy and Pharmacology.
[21] S. Kyo,et al. A simple biological imaging system for detecting viable human circulating tumor cells. , 2009, The Journal of clinical investigation.
[22] R. Kerbel,et al. The multiple personality disorder phenotype(s) of circulating endothelial cells in cancer. , 2009, Biochimica et biophysica acta.
[23] Alison Stopeck,et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. , 2004, The New England journal of medicine.
[24] S. Singletary,et al. Revision of breast cancer staging: the 6th edition of the TNM Classification. , 2003, Seminars in surgical oncology.
[25] K. Schütze,et al. Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells. , 2000, The American journal of pathology.
[26] Nada Jabado,et al. Circulating tumor cells: detection, molecular profiling and future prospects , 2007, Expert review of proteomics.
[27] M. McCutcheon,et al. Studies on the mechanisms of metastasis; the distribution of tumors in various organs in relation to the distribution of arterial emboli. , 1951, Cancer research.
[28] Sabine Riethdorf,et al. Circulating Tumor Cells and Bone Marrow Micrometastasis , 2008, Clinical Cancer Research.
[29] Jamel Chelly,et al. Illegitimate transcription: Its use in the study of inherited disease , 1992, Human mutation.
[30] R. Eils,et al. Systemic spread is an early step in breast cancer. , 2008, Cancer cell.
[31] J. Rak,et al. Vascular determinants of cancer stem cell dormancy—do age and coagulation system play a role? , 2008, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[32] W. Gerald,et al. Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] L. Weiss,et al. Observations on the Antiquity of Cancer and Metastasis , 2000, Cancer and Metastasis Reviews.
[34] S. Shousha,et al. Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. , 1994, Cancer research.
[35] Stefan Sleijfer,et al. Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer. , 2009, Cancer treatment reviews.
[36] R. Ghossein,et al. Review: polymerase chain reaction detection of micrometastases and circulating tumor cells: application to melanoma, prostate, and thyroid carcinomas. , 1999, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[37] Peter Kuhn,et al. A rare-cell detector for cancer. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[38] Veit Zieglschmid,et al. Combination of immunomagnetic enrichment with multiplex RT-PCR analysis for the detection of disseminated tumor cells. , 2005, Anticancer research.
[39] Ulrich Keilholz,et al. Circulating tumor cells: the 'leukemic phase' of solid cancers. , 2006, Trends in molecular medicine.
[40] P. Paterlini-Bréchot,et al. Circulating tumor cells (CTC) detection: clinical impact and future directions. , 2007, Cancer letters.
[41] Tanja Fehm,et al. Circulating Tumor Cells in Patients with Breast Cancer Dormancy , 2004, Clinical Cancer Research.
[42] J. Nesland,et al. Detection of isolated tumor cells in peripheral blood and in BM: evaluation of a new enrichment method. , 2004, Cytotherapy.
[43] J. Rosai,et al. Molecular detection of micrometastases and circulating tumor cells in solid tumors. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[44] L. Weiss,et al. Metastasis of cancer: a conceptual history from antiquity to the 1990s. , 2000, Cancer metastasis reviews.
[45] J. Köllermann,et al. Heterogeneous proliferative potential of occult metastatic cells in bone marrow of patients with solid epithelial tumors , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[46] C. Sotiriou,et al. Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.